News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sidec Technologies AB Expands Into New Offices



5/6/2008 8:49:35 AM

KISTA, Sweden, May 6 /PRNewswire/ -- Sidec has moved to new 800 m2 (8600 square-foot) facility enabling further growth and recruiting of new staff. During the past 12 months, Sidec has doubled the number of employees by recruiting additional Protein Tomography(TM) analysts, sales representatives and expanding its Marketing and R&D teams.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/294289 )

Sidec AB, announces today that it has moved to a new facility in Kista, Sweden. The new 8600 square-foot facility will enable Sidec to continue its market expansion and to recruit further new staff. In the past 12 month Sidec has grown from 20 to 40 employees.

Sidec is the leading provider of three-dimensional (3D) images of individual proteins visualizing and interpreting drug-target interaction in situ and in vitro for a rapid localization of antibody binding epitopes and validation of molecular mode of action.

With Sidec's proprietary technology; Protein Tomography(TM), it is possible to study monoclonal antibody/receptor interactions and reveal the molecular impact of the drug molecule on its target.

"This unique and new technology enables you to actually see the individual molecules in situ to define the epitopes and protect your intellectual property with visual evidence, as well as prioritizing the most promising projects." Says Hans Johansson CEO Sidec . "This new facility combined with a rapidly growing interest from our customers and EUR 7 million provided last year by our owners Investor Growth Capital, EarlyBird Ventures and Industrifonden will enable Sidec to expand to its full potential.

About Sidec:

Sidec studies molecular interactions in situ and in vitro using its proprietary technology Protein Tomography(TM). Sidec AB offers collaborative research projects to the biopharmaceutical industry that reveal unique information to prioritize the most promising therapeutic antibody and to locate the antibody binding epitope.

The company's new location is Torshamnsgatan 30A, SE-164 40 Kista, Sweden.

http://www.sidec.com

CONTACT: For more information, please contact: Hans Johansson, CEO, Phone:
+46-8-5600-2102, E-mail: hans.johansson@sidec.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES